Published in Nat Commun on January 01, 2013
Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. Nat Med (2017) 1.22
A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12. EMBO Mol Med (2014) 0.99
Molecular pathways: aspirin and Wnt signaling-a molecularly targeted approach to cancer prevention and treatment. Clin Cancer Res (2014) 0.96
Wnt signaling in cancer. Oncogene (2016) 0.95
Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression. J Exp Clin Cancer Res (2014) 0.93
Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling. Elife (2015) 0.90
Chemical Disruption of Wnt-dependent Cell Fate Decision-making Mechanisms in Cancer and Regenerative Medicine. Curr Med Chem (2015) 0.89
WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. Oncogene (2015) 0.89
Testing models of the APC tumor suppressor/β-catenin interaction reshapes our view of the destruction complex in Wnt signaling. Genetics (2014) 0.89
Paracrine factors from adipose-mesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model. Cancer Cell Int (2015) 0.88
Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer. Oncotarget (2015) 0.88
Elf3 drives β-catenin transactivation and associates with poor prognosis in colorectal cancer. Cell Death Dis (2014) 0.86
Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer. BMC Cancer (2014) 0.85
Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. Nat Mater (2016) 0.85
microRNA regulation of Wnt signaling pathways in development and disease. Cell Signal (2015) 0.84
Wnt ligand-dependent activation of the negative feedback regulator Nkd1. Mol Biol Cell (2015) 0.83
TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma. Cell Death Differ (2016) 0.82
ATG4B promotes colorectal cancer growth independent of autophagic flux. Autophagy (2014) 0.82
Mathematical modeling links Wnt signaling to emergent patterns of metabolism in colon cancer. Mol Syst Biol (2017) 0.82
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer. Oncotarget (2015) 0.81
Frizzled 7 expression is positively regulated by SIRT1 and β-catenin in breast cancer cells. PLoS One (2014) 0.81
Hypothesis: cell signalling influences age-related risk of colorectal cancer. J Cell Mol Med (2014) 0.79
Wnt2 complements Wnt/β-catenin signaling in colorectal cancer. Oncotarget (2015) 0.78
Comprehensive profiling reveals mechanisms of SOX2-mediated cell fate specification in human ESCs and NPCs. Cell Res (2016) 0.78
Role of retinoids in the prevention and treatment of colorectal cancer. World J Gastrointest Oncol (2015) 0.76
Divergent effects of Porcupine and Wntless on WNT1 trafficking, secretion, and signaling. Exp Cell Res (2016) 0.75
Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis. Onco Targets Ther (2016) 0.75
Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer. Mol Cancer (2017) 0.75
Molecular control of nitric oxide synthesis through eNOS and caveolin-1 interaction regulates osteogenic differentiation of adipose-derived stem cells by modulation of Wnt/β-catenin signaling. Stem Cell Res Ther (2016) 0.75
Wnt9A Induction Linked to Suppression of Human Colorectal Cancer Cell Proliferation. Int J Mol Sci (2016) 0.75
Oncogenic retinoic acid receptor γ knockdown reverses multi-drug resistance of human colorectal cancer via Wnt/β-catenin pathway. Cell Cycle (2017) 0.75
Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling. Oncotarget (2017) 0.75
SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer. Oncotarget (2017) 0.75
Refining Pathways: A Model Comparison Approach. PLoS One (2016) 0.75
Differential expression of mucins in Middle Eastern patients with colorectal cancer. Oncol Lett (2016) 0.75
The Influence of Spirulina platensis Filtrates on Caco-2 Proliferative Activity and Expression of Apoptosis-Related microRNAs and mRNA. Mar Drugs (2017) 0.75
APC haploinsufficiency coupled with p53 loss sufficiently induces mucinous cystic neoplasms and invasive pancreatic carcinoma in mice. Oncogene (2015) 0.75
Blocking Wnt Secretion Reduces Growth of Hepatocellular Carcinoma Cell Lines Mostly Independent of β-Catenin Signaling. Neoplasia (2016) 0.75
Wntless-Sec12 complex on ER membrane regulates early Wnt secretory vesicle assembly and mature ligand export. J Cell Sci (2017) 0.75
Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model. PLoS One (2017) 0.75
Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families. FASEB J (2017) 0.75
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
Comprehensive molecular characterization of human colon and rectal cancer. Nature (2012) 34.13
The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol (2004) 24.63
Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science (1997) 24.61
Wnt signalling in stem cells and cancer. Nature (2005) 19.26
Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature (2010) 10.60
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol (2009) 9.43
Wnt signalling and its impact on development and cancer. Nat Rev Cancer (2008) 8.37
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 7.78
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol (2010) 7.73
Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature (2011) 6.09
Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res (1998) 5.80
Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev (2004) 5.66
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature (2005) 5.50
Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet (1992) 5.14
Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev Cell (2006) 4.89
Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature (2005) 4.88
The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell (2011) 4.79
APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer (2001) 4.54
R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A (2011) 4.52
Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell (2006) 4.09
Secretion of Wnt ligands requires Evi, a conserved transmembrane protein. Cell (2006) 4.01
Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat Genet (2002) 3.60
The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res (1994) 3.57
The retromer complex influences Wnt secretion by recycling wntless from endosomes to the trans-Golgi network. Dev Cell (2007) 3.00
LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling. EMBO Rep (2011) 2.77
The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet (2002) 2.69
Colonic crypt organization and tumorigenesis. Nat Rev Cancer (2008) 2.66
Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. Gastroenterology (2012) 2.57
Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell (2011) 2.47
Differential requirement for the dual functions of β-catenin in embryonic stem cell self-renewal and germ layer formation. Nat Cell Biol (2011) 2.32
Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PLoS One (2010) 2.28
The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res (2004) 2.16
Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev (1999) 1.95
Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature (2011) 1.91
Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res (1997) 1.91
Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol Biol Cell (2000) 1.87
Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. J Cell Biol (2007) 1.77
Smed-Evi/Wntless is required for beta-catenin-dependent and -independent processes during planarian regeneration. Development (2009) 1.73
Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol (2000) 1.66
Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation. Am J Pathol (2000) 1.56
APC is essential for targeting phosphorylated beta-catenin to the SCFbeta-TrCP ubiquitin ligase. Mol Cell (2008) 1.54
Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells. J Cell Sci (2002) 1.50
Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer. Int J Cancer (2007) 1.48
Diverse chemical scaffolds support direct inhibition of the membrane-bound O-acyltransferase porcupine. J Biol Chem (2012) 1.33
Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice. Gastroenterology (2012) 1.32
APC dosage effects in tumorigenesis and stem cell differentiation. Int J Dev Biol (2004) 1.29
Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A (2011) 1.29
Deconstructing the ßcatenin destruction complex: mechanistic roles for the tumor suppressor APC in regulating Wnt signaling. Mol Biol Cell (2011) 1.21
Disease model: familial adenomatous polyposis. Trends Mol Med (2001) 1.10
The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis. EMBO Mol Med (2011) 1.10
Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis. Oncogene (2011) 1.07
Colorectal cancers choosing sides. Biochim Biophys Acta (2011) 1.04
Truncated APC regulates the transcriptional activity of beta-catenin in a cell cycle dependent manner. Hum Mol Genet (2006) 0.97
A common role for various human truncated adenomatous polyposis coli isoforms in the control of beta-catenin activity and cell proliferation. PLoS One (2012) 0.93
Dickkopf-4 is frequently down-regulated and inhibits growth of colorectal cancer cells. Cancer Lett (2008) 0.91
Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation. PLoS One (2013) 0.90
APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC. Hum Mol Genet (2011) 0.90
Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients. Oncogene (2009) 0.84
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med (2006) 9.68
Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset. Genome Biol (2005) 8.32
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med (2006) 7.42
Estimating amino acid substitution models: a comparison of Dayhoff's estimator, the resolvent approach and a maximum likelihood method. Mol Biol Evol (2002) 7.03
An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol (2011) 6.44
The promise and perils of Wnt signaling through beta-catenin. Science (2002) 6.11
Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods (2006) 5.96
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med (2010) 4.76
Secretion of Wnt ligands requires Evi, a conserved transmembrane protein. Cell (2006) 4.01
Target-specific requirements for enhancers of decapping in miRNA-mediated gene silencing. Genes Dev (2007) 3.92
High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat Methods (2007) 3.90
Inferring cellular networks--a review. BMC Bioinformatics (2007) 3.49
Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J Clin Invest (2007) 3.28
Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med (2010) 3.09
Signaling role of hemocytes in Drosophila JAK/STAT-dependent response to septic injury. Dev Cell (2003) 3.05
Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science (2010) 3.04
Identification of JAK/STAT signalling components by genome-wide RNA interference. Nature (2005) 2.90
Active Wnt proteins are secreted on exosomes. Nat Cell Biol (2012) 2.81
Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J Clin Invest (2007) 2.80
LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling. EMBO Rep (2011) 2.77
Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res (2007) 2.62
Cell cycle control of wnt receptor activation. Dev Cell (2009) 2.52
Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. Neuron (2002) 2.52
Mapping of signaling networks through synthetic genetic interaction analysis by RNAi. Nat Methods (2011) 2.47
Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell (2011) 2.47
T cells become licensed in the lung to enter the central nervous system. Nature (2012) 2.45
FlyRNAi: the Drosophila RNAi screening center database. Nucleic Acids Res (2006) 2.43
A largely random AAV integration profile after LPLD gene therapy. Nat Med (2013) 2.42
EBImage--an R package for image processing with applications to cellular phenotypes. Bioinformatics (2010) 2.42
Akirins are highly conserved nuclear proteins required for NF-kappaB-dependent gene expression in drosophila and mice. Nat Immunol (2007) 2.36
Beta phorbol ester- and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs. Cell (2002) 2.31
BRAF inhibition in refractory hairy-cell leukemia. N Engl J Med (2012) 2.25
Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nat Protoc (2010) 2.24
Comprehensive genomic access to vector integration in clinical gene therapy. Nat Med (2009) 2.19
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet (2012) 2.07
Clustering phenotype populations by genome-wide RNAi and multiparametric imaging. Mol Syst Biol (2010) 2.03
Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Sci Transl Med (2014) 2.00
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood (2008) 1.97
Nested effects models for high-dimensional phenotyping screens. Bioinformatics (2007) 1.84
High-throughput RNA interference screens in Drosophila tissue culture cells. Methods Enzymol (2005) 1.83
Electrochemical cues regulate assembly of the Frizzled/Dishevelled complex at the plasma membrane during planar epithelial polarization. Nat Cell Biol (2009) 1.80
Finding disease specific alterations in the co-expression of genes. Bioinformatics (2004) 1.78
Non-transcriptional pathway features reconstructed from secondary effects of RNA interference. Bioinformatics (2005) 1.78
Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res (2010) 1.76
Smed-Evi/Wntless is required for beta-catenin-dependent and -independent processes during planarian regeneration. Development (2009) 1.73
Mapping genetic interactions in human cancer cells with RNAi and multiparametric phenotyping. Nat Methods (2013) 1.72
Mapping segmental and sequence variations among laboratory mice using BAC array CGH. Genome Res (2005) 1.71
E-RNAi: a web application to design optimized RNAi constructs. Nucleic Acids Res (2005) 1.69
An RNA interference screen identifies Inhibitor of Apoptosis Protein 2 as a regulator of innate immune signalling in Drosophila. EMBO Rep (2005) 1.67
GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes, 2013 update. Nucleic Acids Res (2012) 1.63
A stochastic downhill search algorithm for estimating the local false discovery rate. IEEE/ACM Trans Comput Biol Bioinform (2006) 1.62
Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells. J Am Soc Nephrol (2006) 1.50
Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. Blood (2014) 1.50
Identification of SUMO-dependent chromatin-associated transcriptional repression components by a genome-wide RNAi screen. Mol Cell (2008) 1.48
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood (2008) 1.47
Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5. Biochem J (2006) 1.46
Temporal ChIP-on-chip reveals Biniou as a universal regulator of the visceral muscle transcriptional network. Genes Dev (2007) 1.43
The head-regeneration transcriptome of the planarian Schmidtea mediterranea. Genome Biol (2011) 1.41
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood (2011) 1.39
A combined ex vivo and in vivo RNAi screen for notch regulators in Drosophila reveals an extensive notch interaction network. Dev Cell (2010) 1.38
Regulation of Wnt protein secretion and its role in gradient formation. EMBO Rep (2008) 1.35
Proteins required for centrosome clustering in cancer cells. Sci Transl Med (2010) 1.35
SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression. Blood (2009) 1.33
Microarray based diagnosis profits from better documentation of gene expression signatures. PLoS Comput Biol (2008) 1.33
Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial. Blood (2004) 1.32
Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. Mol Cell (2012) 1.29
Automated in-silico detection of cell populations in flow cytometry readouts and its application to leukemia disease monitoring. BMC Bioinformatics (2006) 1.29
Differential myocardial gene expression in the development and rescue of murine heart failure. Physiol Genomics (2003) 1.28
Proteomic and functional analysis of the mitotic Drosophila centrosome. EMBO J (2010) 1.27
Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. Blood (2012) 1.27
On target: a public repository for large-scale RNAi experiments. Nat Cell Biol (2012) 1.27
Detecting hierarchical structure in molecular characteristics of disease using transitive approximations of directed graphs. Bioinformatics (2008) 1.26
Drosophila Ras/MAPK signalling regulates innate immune responses in immune and intestinal stem cells. EMBO J (2011) 1.26
Similarities of ordered gene lists. J Bioinform Comput Biol (2006) 1.26
OrderedList--a bioconductor package for detecting similarity in ordered gene lists. Bioinformatics (2006) 1.25
Genomic mapping of binding regions for the Ecdysone receptor protein complex. Genome Res (2009) 1.24
web cellHTS2: a web-application for the analysis of high-throughput screening data. BMC Bioinformatics (2010) 1.23
Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma. PLoS One (2011) 1.22
Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites. Hum Gene Ther Methods (2012) 1.21
E-RNAi: a web application for the multi-species design of RNAi reagents--2010 update. Nucleic Acids Res (2010) 1.21
Design and evaluation of genome-wide libraries for RNA interference screens. Genome Biol (2010) 1.20
GenomeRNAi: a database for cell-based RNAi phenotypes. 2009 update. Nucleic Acids Res (2009) 1.20
GenomeRNAi: a database for cell-based RNAi phenotypes. Nucleic Acids Res (2006) 1.20
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines. Nucleic Acids Res (2013) 1.20
Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells. Mol Ther (2002) 1.18
Modeling the temporal interplay of molecular signaling and gene expression by using dynamic nested effects models. Proc Natl Acad Sci U S A (2009) 1.17
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia. Br J Haematol (2013) 1.16
Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma. Haematologica (2008) 1.15
Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc Res (2003) 1.14
Real-time definition of non-randomness in the distribution of genomic events. PLoS One (2007) 1.14
ERK7 is a negative regulator of protein secretion in response to amino-acid starvation by modulating Sec16 membrane association. EMBO J (2011) 1.13
Human beta-defensin-3 promotes wound healing in infected diabetic wounds. J Gene Med (2009) 1.13
Wnt/Frizzled signaling requires dPRR, the Drosophila homolog of the prorenin receptor. Curr Biol (2010) 1.11
State-of-the art data normalization methods improve NMR-based metabolomic analysis. Metabolomics (2011) 1.11